Investor Communications
Q&A Regarding the Merger Transaction
NorthStar Healthcare’s Q3 2024 Results and Business Update Conference Call
Supplemental Financial Reports
Year Ended 2024 Financial Supplement – 3.18.2025
Third Quarter Ended 2024 Financial Supplement – 11.08.2024
Second Quarter Ended 2024 Financial Supplement – 8.12.2024
First Quarter Ended 2024 Financial Supplement – 5.09.2024
Year Ended 2023 Financial Supplement – 3.22.2024
Third Quarter 2023 Financial Supplement and Estimated Net Asset Value – 11.14.2023
Second Quarter 2023 Financial Supplement – 08.14.2023
First Quarter 2023 Financial Supplement – 05.10.2023
Click here for previous Supplemental Financial Reports
Shareholder Letters
Response to Comrit Tender Offer – 10.17.2024
June 30, 2024 Estimated Per Share Value – 10.17.2024
Response to West 4 Tender Offer – 08.12.2024
Response to Comrit Tender Offer – 05.01.2024
Response to Comrit Tender Offer – 01.11.2024
June 30, 2023 Estimated Per Share Value – 11.14.2023
Response to Comrit Tender Offer – 03.10.2023
Investor Presentation - Internalization of Management
Investor Presentation NHI Internalization, October 2022